CATALYSTYahoo Finance • 18h ago
iRhythm Holdings (IRTC) Stock May Be A Bargain After Data Breach ProbeYahoo Finance report covering iRhythm Holdings Inc. (IRTC) market action, institutional positioning, and fundamental catalysts.
Why IRTC Stock dropped -3.47% Today — RQD Quant Desk Flash
$123.37 -3.47% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)
EXT / AFTER-HRS: $122.37
iRhythm Holdings Inc. (IRTC) carries a Roarable Rating of D (Sell) with 47/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
ROARABLE D • SELL / AVOID
Cap $4.07B
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER
Click Any Pre-Computed AI Quant Specialist Briefing on IRTC Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief)
Is IRTC stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼
As of 2026-11-03, iRhythm Holdings Inc. (NASDAQ: IRTC) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 47/100 at a spot price of $123.37 (-3.47% 1D, market cap $4.07B). Pillar breakdown: Fundamental Cash Engine 12/20, Institutional 13F & Options Flow 11/20, Executive Insider Alignment 9/20, FRED Macro Regime Fit 6/20, and SEC Balance-Sheet Forensics 9/20. Across 1016 tracked Health Care issuers, IRTC ranks #298 in composite RQD confidence.
✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief)
How does IRTC compare to ICUI and NVST in the Health Care sector?
▼
Within the Health Care sector (Medical/Dental Instruments), IRTC carries a Roarable D (47/100 RQD), trailing P/E of N/A, gross margin of 70.6%, and ROIC of -13.5%. By comparison, ICUI (ICU Medical Inc.) holds a D+ grade (56/100 RQD, P/E N/A, ROIC 1.0%, cap $4.10B) and NVST (Envista Holdings Corporation) posts a D grade (46/100 RQD, P/E 84.1x, ROIC 5.1%, cap $3.78B). Among the 5-stock peer group, NVST leads on earnings multiple (84.1x) while NVST leads on capital efficiency (5.1% ROIC).
✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief)
What are the biggest fundamental strengths and SEC risk factors for IRTC?
▼
Per IRTC's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001388658), iRhythm Holdings Inc. generated $747.1M in revenue (+26.2% YoY), -$45.0M in net income, and $34.5M in free cash flow against $1.02B in total assets and $390.3M in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
EXT / AFTER-HRS: $122.37 (-0.81%)🧬 Disciplined Float (+0.80% YoY Shares)⚙️ Cash Engine: 12/20 (C-) • 4.6% FCF Margin
Verify 90D Bucket Audit →📊 Historical Track Record Warning: Scores below 50 (47/100 · D) historically underperformed SPY in 71% of rolling 90-day windows (-5.9% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →RQD QUANT TACHOMETERSELL / AVOID • D
2-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR SNOWFLAKE RADARRw D+ · Rk D-
Each axis scored 0–20
12M PRICE TARGET CONE-5% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for IRTC)Realized 20D OHLCV Swing Band: ±7.8%
Deterministic 5-Pillar Attribution (47/100 Composite)
🔍 WHY IRTC SCORES 47/100 (D) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Cash Engine Quality+12/20 pts (26% of score)
SEC XBRL FY 2025 (10-K): 4.6% FCF Margin ($34.5M FCF) & 70.6% Gross Margin
▲ #2 Bullish Driver: Whale & Options Positioning+11/20 pts (23% of score)
20D Institutional Volume Accumulation (±7.8% realized swing band)
▼ #1 Drag / Risk Factor: Macro Regime Fit6/20 pts (-14 pt drag)
Macro rate sensitivity & RSI-14 (58.9) create a -14 pt regime headwind
📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)Grade E$106.05+7.1% Next Q
39
Q2 (-2Q)Grade D$113.55+9.2% Next Q
42
Q3 (-1Q)Grade D$123.99-0.5% Next Q
44
CurrentGrade D$123.37-5.9% Hist 90D α
47
Trajectory: E (39) → D (47)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER
⚔️ Adversarial Opposing Case: What Could Spark a IRTC Turnaround Squeeze
While IRTC currently carries a cautious 47/100 (D) rating due to Macro Regime Fit (6/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
🚀 Contrarian Squeeze Trigger #1
Established market leader in Health Care with deep daily trading liquidity.
🚀 Contrarian Squeeze Trigger #2
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($115.08) and Max Pain ($129.54) forces dealer call-delta covering toward $202.09.
🚀 Contrarian Squeeze Trigger #3
Forensic Repair Trigger: Halting share dilution (Disciplined Float (+0.80% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
🎲 LIVE PREDICTION MARKET ODDS TIED TO $IRTC• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “IRTC Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why IRTC Stock dropped -3.47% Today — RQD Quant Desk Flash
iRhythm Holdings Inc. (IRTC) dropped -3.47% to $123.37, trading at 25% of its 52-week range ($100.7 – $192.47). Stretched risk/reward at current multiples (-14% return on capital) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 25% of its 52-week range ($100.7 – $192.47) with RSI-14 at 58.9 (BULLISH MOMENTUM).
- ▸Volatility Profile: Historical 20-day realized swing band of ±7.8% around $123.37 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable D (Sell) backed by 70.6% gross margin and $34.5M annual free cash flow.
Live IRTC Headlines & Catalysts
MARKET WIRESeeking Alpha • 21h ago
iRhythm stock a new Overweight at Piper Sandler (IRTC:NASDAQ)Seeking Alpha report covering iRhythm Holdings Inc. (IRTC) market action, institutional positioning, and fundamental catalysts.
MARKET WIREInvesting.com • 1d ago
iRhythm Holdings stock hits 52-week low at $100.70Investing.com report covering iRhythm Holdings Inc. (IRTC) market action, institutional positioning, and fundamental catalysts.
RISK WATCHYahoo Finance • 1d ago
iRhythm (IRTC) Stock Sees Modest Fair Value Cut After VitalConnect And Zio MCT QuestionsYahoo Finance report covering iRhythm Holdings Inc. (IRTC) market action, institutional positioning, and fundamental catalysts.
CATALYSTTradingView • 1d ago
iRhythm completes acquisition of VitalConnect for $237.5M, expects revenue growth boost and 15% adjusted EBITDA target for 2027TradingView report covering iRhythm Holdings Inc. (IRTC) market action, institutional positioning, and fundamental catalysts.
MARKET WIREGuruFocus • 1d ago
iRhythm Holdings (IRTC) Stock Rises on Piper Sandler Overweight Rating and $160 Price TargetGuruFocus report covering iRhythm Holdings Inc. (IRTC) market action, institutional positioning, and fundamental catalysts.
MARKET WIREStock Titan • 1d ago
A heart-monitoring platform can track up to 11 body signals. iRhythm bought VitalConnect.Stock Titan report covering iRhythm Holdings Inc. (IRTC) market action, institutional positioning, and fundamental catalysts.
MARKET WIREStockStory • 1d ago
2 Unprofitable Stocks with Competitive Advantages and 1 We Brush OffStockStory report covering iRhythm Holdings Inc. (IRTC) market action, institutional positioning, and fundamental catalysts.
CATALYSTYahoo • 4d ago
iRhythm Holdings, Inc. (IRTC) Earnings Expected to Grow: Should You Buy?IRHYTHM HLDGS (IRTC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CATALYSTYahoo • 6d ago
How Positive Free Cash Flow At iRhythm Holdings (IRTC) Has Changed Its Investment StoryiRhythm Holdings has reported 24% annual revenue growth over the last two years and recently moved into positive free cash flow, signaling improved operating efficiency and stronger commercial traction for its wearable c
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring IRTC)
- ✓Walkthrough of IRTC's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
IRTC // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +3.52%📐 HORIZONTAL RANGE
2026-11-03O $127.8H $127.8L $123.4C $123.4VOL 533.5K
RES: $128.2SUP: $99.12SMA50: $115.1SMA200: $121.8
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
IRTC Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor (#25)
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle (#30)
23.1%/yr Implied 5Y Growth
vs. +26.2% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger (#33)
No active Ellis Vennor swing setup published on IRTC today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for IRTC. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for IRTC today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (IRTC)
Health Care Rank #298 of 1016
⚔️ ICUI vs IRTC Full Matrix →
1. Head-to-Head Health Care Peer Comparison (IRTC vs. ICUI, NVST, PLSE, HTFL)
Industry: Medical/Dental Instruments (120 Tracked Issuers)Across 1016 tracked Health Care securities in the Roarable RQD universe, iRhythm Holdings Inc. (IRTC) ranks #298 by composite RQD confidence (47/100, grade D) and #178 by equity capitalization ($4.07B). Within this direct 5-issuer industry benchmark cohort, NVST leads on earnings valuation at 84.1x trailing P/E, while NVST leads on capital efficiency and profitability with 5.1% ROIC and 54.7% gross margin. ICUI currently holds the highest overall quantitative score in the immediate peer group at 56/100 (D+) compared with IRTC at 47/100 (D).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| IRTC
ACTIVE
iRhythm Holdings Inc. | D | 47/100 | — | 70.6% | -13.5% | -3.47% | $4.07B | Benchmark Subject |
| ICUI ICU Medical Inc. | D+ | 56/100 | — | 36.8% | 1.0% | -2.89% | $4.10B | /icui-vs-irtc → |
| NVST Envista Holdings Corporation | D | 46/100 | 84.1x | 54.7% | 5.1% | -4.47% | $3.78B | /nvst-vs-irtc → |
| PLSE Pulse Biosciences Inc | D- | 39/100 | — | -30.0% | -30.7% | -5.84% | $3.73B | /plse-vs-irtc → |
| HTFL Heartflow Inc. | D+ | 53/100 | — | 76.8% | -12.0% | -2.44% | $5.13B | /htfl-vs-irtc → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001388658In its most recent audited fiscal period (FY2025, filed 2025-12-31), iRhythm Holdings Inc. (IRTC) reported GAAP revenue of $747.1M (+26.2% vs. FY2024 revenue of $591.8M , and +51.6% cumulative change since FY2023) , GAAP net income of -$45.0M, operating cash flow of $80.9M, and free cash flow of $34.5M (+213.0% YoY). On the balance sheet, IRTC closed FY2025 with $1.02B in total assets against $390.3M in total debt (Altman Z-Score: 3.01, Piotroski F-Score: 7/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $747.1M | -$45.0M | $80.9M | $34.5M | $1.02B | $390.3M |
| FY2024 (FY) | 2024-12-31 | $591.8M | -$113.0M | $3.4M | -$30.6M | $931.4M | $378.2M |
| FY2023 (FY) | 2023-12-31 | $492.7M | -$123.0M | -$50.1M | -$72.3M | $2.32B | $542.2M |
3. IRTC Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs IRTC stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-03, iRhythm Holdings Inc. (NASDAQ: IRTC) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 47/100 at a spot price of $123.37 (-3.47% 1D, market cap $4.07B). Pillar breakdown: Fundamental Cash Engine 12/20, Institutional 13F & Options Flow 11/20, Executive Insider Alignment 9/20, FRED Macro Regime Fit 6/20, and SEC Balance-Sheet Forensics 9/20. Across 1016 tracked Health Care issuers, IRTC ranks #298 in composite RQD confidence.
How does IRTC compare to ICUI and NVST in the Health Care sector?
Within the Health Care sector (Medical/Dental Instruments), IRTC carries a Roarable D (47/100 RQD), trailing P/E of N/A, gross margin of 70.6%, and ROIC of -13.5%. By comparison, ICUI (ICU Medical Inc.) holds a D+ grade (56/100 RQD, P/E N/A, ROIC 1.0%, cap $4.10B) and NVST (Envista Holdings Corporation) posts a D grade (46/100 RQD, P/E 84.1x, ROIC 5.1%, cap $3.78B). Among the 5-stock peer group, NVST leads on earnings multiple (84.1x) while NVST leads on capital efficiency (5.1% ROIC).
What are the biggest fundamental strengths and SEC risk factors for IRTC?
Per IRTC's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001388658), iRhythm Holdings Inc. generated $747.1M in revenue (+26.2% YoY), -$45.0M in net income, and $34.5M in free cash flow against $1.02B in total assets and $390.3M in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is IRTC trading relative to its 50-day, 200-day, and 52-week technical levels?
IRTC last traded at $123.37 (-3.47% on volume of 533,468 shares), positioning the stock +7.20% above its 50-day simple moving average ($115.08) and +1.33% above its 200-day simple moving average ($121.75). Across its 52-week range of $100.70 to $192.47, IRTC sits at the 24.7% percentile with a 14-day RSI of 58.9 (BULLISH MOMENTUM) and an implied next-earnings move of ±7.8% ($113.75 to $132.99).
IRTC Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is IRTC stock moving today?
Why IRTC Stock dropped -3.47% Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (-14% return on capital) under elevated 10-year interest-rate pressure.
ROARABLE RATING BRIEF • RQD 47/100 (D)
✓ STAGE-C NUMBER FIREWALL VERIFIED
IRTC — iRhythm Holdings Inc.: What the Facts Mean to a Prospective Investor
Engine: anthropic/claude-haiku-5.5
As of: 2026-11-02T15:22:02Z
Roarable Rating Brief: What This Means to a Prospective Investor
Per the Roarable RQD rating, IRTC scores 48 out of 100 with a letter grade of D, labeled "Roarable Sell — Underperform / Distribution Warning." The five pillars are:
- Fundamental Cash Engine (12 / 20): Per the Roarable RQD rating, ROIC is -13.5% and FCF yield is 0.82%. Investor implication: the business is not currently generating returns above its cost of capital, and the cash yield on the current price is thin.
- Whale 13F Flow (12 / 20): Per the Roarable RQD rating, this pillar reflects institutional accumulation and options positioning. Investor implication: institutional positioning is neutral-to-moderate rather than a strong tailwind.
- Insider Conviction (9 / 20): Per the Roarable RQD rating, this pillar reflects SEC Form 4 and Congressional PTR cluster flow. Investor implication: insider and congressional activity does not provide strong conviction support.
- Macro Regime Fit (6 / 20): Per the Roarable RQD rating, beta is 0.98 with sector sensitivity. Investor implication: the stock moves roughly in line with the market, and this pillar is the weakest, suggesting limited regime-based support.
- Forensic Balance Sheet (9 / 20): Per the Roarable RQD rating, Altman Z is 3.01, Piotroski F is 7/9, and Debt/Equity is 2.38. Investor implication: the Altman Z reading and Piotroski score are relatively constructive, but leverage on a debt-to-equity basis is high.
Taken together, the pillar profile points to a business with a weak cash-return profile, high leverage relative to equity, and limited macro or insider tailwinds, offset partly by a respectable forensic score. Valuation tradeoffs are visible in the forward P/E of 30 against negative trailing EPS. Upside drivers would need to come from margin recovery and cash conversion; downside risk is elevated given the distribution-warning verdict.
Business
Per the profile, iRhythm Holdings Inc. is a NASDAQ-listed issuer in the Health Care sector, Medical/Dental Instruments industry. Per the SEC financials, FY 2025 revenue was $747.1M. Per the market data, gross margin is 70.6%. Not available in source data: a detailed description of products, customer segments, or revenue model.
Financial Trend
| Period | Revenue | Operating Income | Net Income | EPS | FCF | Cash | Debt |
|---|---|---|---|---|---|---|---|
| FY 2025 | $747.1M | $-57.4M | $-45.0M | N/A | $34.5M | $236.0M | $390.3M |
| FY 2024 | $591.8M | $-115.5M | $-113.0M | N/A | $-30.6M | $419.6M | $378.2M |
| FY 2023 | $492.7M | $-125.2M | $-123.0M | N/A | $-72.3M | N/A | $542.2M |
Per the SEC financials, revenue grew from $492.7M (FY 2023) to $747.1M (FY 2025), while operating losses narrowed from $-125.2M to $-57.4M. Per the market data, operating margin is -7.7% and net margin is -6%. ROIC is -13.5% per the market data. Per the Roarable RQD rating, the Altman Z-Score is 3.01 and the Piotroski F-Score is 7/9, while Debt/Equity is 2.38. Cash declined from $419.6M to $236.0M over FY 2024 to FY 2025 while debt rose slightly from $378.2M to $390.3M.
Recent Catalysts & News Wire Analysis
- Catalyst (green): Yahoo Finance reported on the stock as a possible bargain following a data breach probe.
- Catalyst (green): TradingView reported that iRhythm completed the acquisition of VitalConnect for $237.5M and expects a revenue growth boost and a 15% adjusted EBITDA target for 2027.
- Market wire (yellow): Seeking Alpha reported a new Overweight rating from Piper Sandler.
- Market wire (yellow): Investing.com reported the stock hit a 52-week low at $100.70.
- Market wire (yellow): GuruFocus reported a rise on the Piper Sandler Overweight rating and a $160 price target.
- Risk watch (red): Yahoo Finance reported a modest fair value cut following VitalConnect and Zio MCT questions.
Per the Butterfly Supply-Chain Graph, supply chain is listed as NONE, with no butterfly links and no proprietary signals.
Open Questions
- What is the trailing P/E and EV/EBITDA, which are marked unavailable in the source data?
- What is the specific revenue and margin contribution expected from the VitalConnect acquisition, and when does the 15% adjusted EBITDA target apply?
- What is the nature and scope of the data breach probe referenced in the news flow?
- What are the terms and risk profile of the $390.3M debt, and what drove the decline in cash from $419.6M to $236.0M?
- What drives the difference between the Piper Sandler $160 target and the current $127.8 price in the context of negative trailing EPS?
IRTC Live News Feed, Press Releases & Catalyst Wire
Real-time company headlines, analyst actions, and sector developments for iRhythm Holdings Inc. (IRTC) • Click "Debate This Headline" to argue it in the Roar Pit below
🟢 CATALYST Yahoo Finance • 18h ago
iRhythm Holdings (IRTC) Stock May Be A Bargain After Data Breach Probe Yahoo Finance report covering iRhythm Holdings Inc. (IRTC) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Seeking Alpha • 21h ago
iRhythm stock a new Overweight at Piper Sandler (IRTC:NASDAQ) Seeking Alpha report covering iRhythm Holdings Inc. (IRTC) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Investing.com • 1d ago
iRhythm Holdings stock hits 52-week low at $100.70 Investing.com report covering iRhythm Holdings Inc. (IRTC) market action, institutional positioning, and fundamental catalysts.
🔴 RISK WATCH Yahoo Finance • 1d ago
iRhythm (IRTC) Stock Sees Modest Fair Value Cut After VitalConnect And Zio MCT Questions Yahoo Finance report covering iRhythm Holdings Inc. (IRTC) market action, institutional positioning, and fundamental catalysts.
🟢 CATALYST TradingView • 1d ago
iRhythm completes acquisition of VitalConnect for $237.5M, expects revenue growth boost and 15% adjusted EBITDA target for 2027 TradingView report covering iRhythm Holdings Inc. (IRTC) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE GuruFocus • 1d ago
iRhythm Holdings (IRTC) Stock Rises on Piper Sandler Overweight Rating and $160 Price Target GuruFocus report covering iRhythm Holdings Inc. (IRTC) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Stock Titan • 1d ago
A heart-monitoring platform can track up to 11 body signals. iRhythm bought VitalConnect. Stock Titan report covering iRhythm Holdings Inc. (IRTC) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE StockStory • 1d ago
2 Unprofitable Stocks with Competitive Advantages and 1 We Brush Off StockStory report covering iRhythm Holdings Inc. (IRTC) market action, institutional positioning, and fundamental catalysts.
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE
3 Active Posts & Replies
IRTC Bull vs. Bear Conversation Board — What's Your Call at $123.37?
🐂 50% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON IRTC 🐻 50% BEARISH CONVICTION
RO RoarDesk_Moderator Roarable Research Desk ⚖️ DEBATE HOST
🎯 Target: $138.02 (+8.0%)
📌 Pinned Debate 🔥 Official Bull vs. Bear Debate: Is IRTC (D • RQD 48/100) a Buy at $127.80?
Welcome to the IRTC (iRhythm Holdings Inc.) Roar Pit. Current RQD Composite is 48/100 (Roarable Sell — Underperform / Distribution Warning) in Medical/Dental Instruments. Bulls point to operating leverage and sector positioning, while bears focus on macro rate sensitivity and margin execution. Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.
VA ValDiscipline Forensic Accounting Watch 🐻 BEARISH
🎯 Target: $95.85 (-25.0%)
Spot @ $127.80 Pump the brakes on IRTC — check the valuation vs. margin headwinds
Everyone in here is repeating the bull case on IRTC, but look at what you are paying: current EV/EBITDA multiples with 70.6% gross margins. Unless iRhythm Holdings Inc. expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.
CA CashFlowKing Verified K Arena Trader 🐂 BULLISH
🎯 Target: $150.80 (+18.0%)
Spot @ $127.80 IRTC cash flow & RQD setup is being underpriced by the Street here
Looking at the 5-pillar RQD breakdown on IRTC, the market is fixating on short-term headline noise in Medical/Dental Instruments and ignoring the balance sheet and cash flow trajectory. At $127.80 (52-wk range $100.70 - $192.47), any beat on forward guidance forces shorts and underweight funds to chase.